We are live on
!
Find out more
Verrica Pharmaceuticals
VRCA
VRCA
67 hedge funds and large institutions have $58.5M invested in Verrica Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 19 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
6% more funds holding
Funds holding: 63 → 67 (+4)
0.1% more ownership
Funds ownership: 3.48% → 3.58% (+0.1%)
11% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 19
31% less capital invested
Capital invested by funds: $84.2M → $58.5M (-$25.8M)
88% less call options, than puts
Call options by funds: $16K | Put options by funds: $133K
Holders
67
Holders Change
+4
Holders Change %
+6.35%
% of All Funds
1.06%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
17
Reduced
19
Closed
8
Calls
$16K
Puts
$133K
Net Calls
-$117K
Net Calls Change
-$370K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.74M |
| 2 |
CP
Caligan Partners
New York
|
+$1.32M |
| 3 |
BC
Boxer Capital
San Diego,
California
|
+$848K |
| 4 |
Morgan Stanley
New York
|
+$362K |
| 5 |
BlackRock
New York
|
+$242K |
Top Sellers
| 1 |
Millennium Management
New York
|
-$1.18M |
| 2 |
Renaissance Technologies
New York
|
-$463K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$360K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$311K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$197K |
